Pancreatic Cancer Research

ResearcherNippon Medical SchoolNo recent work listed

Hisashi Yoshimura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6498-4529; OpenAlex author ID A5001352072. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 10

  1. Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through H19 Long Non-Coding RNA Expression. Co-author DOI 10.3390/cancers14092055↗
  2. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pan… Co-author DOI 10.3390/cancers12102976↗
  3. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture. Co-author DOI 10.1038/s41598-019-47416-w↗
  4. Pancreatic cancer stem cells: features and detection methods. Co-author DOI 10.1007/s12253-018-0420-x↗
  5. Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis. Co-author DOI 10.1038/s41374-018-0048-1↗
  6. H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.26176↗
  7. Nestin phosphorylation at threonines 315 and 1299 correlates with proliferation and metastasis of human pancreatic cancer. Co-author DOI 10.1111/cas.13139↗
  8. Systemic Administration of Small Interfering RNA Targeting Human Nestin Inhibits Pancreatic Cancer Cell Proliferation and Metastasis. Co-author DOI 10.1097/mpa.0000000000000427↗
  9. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice. First author DOI 10.1016/j.ajpath.2013.11.014↗
  10. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer. First author DOI 10.1111/cas.12470↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshiyuki Ishiwata · 10 shared papers, 2014–2022 · strength 0.85
  2. Yoko Matsuda · 9 shared papers, 2014–2020 · strength 0.69
  3. Norihiko Sasaki · 6 shared papers, 2018–2022 · strength 0.60
  4. Tomio Arai · 6 shared papers, 2016–2019 · strength 0.48
  5. Masashi Toyoda · 4 shared papers, 2018–2022 · strength 0.44
  6. Fujiya Gomi · 3 shared papers, 2019–2022 · strength 0.35
  7. Junko Aida · 4 shared papers, 2018–2019 · strength 0.33
  8. Yuuki Shichi · 2 shared papers, 2019–2022 · strength 0.25
  9. Akira Matsushita · 1 shared paper, 2022 · strength 0.16
  10. Murray Korc · 2 shared papers, 2014–2020 · strength 0.16
  11. Zenya Naito · 2 shared papers, 2014 · strength 0.10
  12. Toshinari Minamoto · 1 shared paper, 2017 · strength 0.08
  13. Toshikazu Ushijima · 1 shared paper, 2016 · strength 0.07
  14. Eiji Uchida · 1 shared paper, 2014 · strength 0.05
  15. Junji Ueda · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.